Evidence map›Paper›PMID 27016017›Full record

ArticleNeuropharmacology2016

Role of interleukin-10 (IL-10) in regulation of GABAergic transmission and acute response to ethanol.

A Suryanarayanan, J M Carter, J D Landin, A L Morrow, D F Werner, I Spigelman

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Deletion of p75Frontiers in molecular neuroscience · 2023
    Article
  11. Article
  12. Article
  13. GABAScientific reports · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

A SuryanarayananDepartment of Pharmaceutical Sciences, University of the Sciences, Philadelphia College of Pharmacy, Philadelphia, PA 19104, USA. Electronic address: a.suryanarayanan@usciences.edu.
J M CarterDepartment of Psychology, Center for Development and Behavioral Neuroscience, Binghamton University, Binghamton, NY 13902, USA.
J D LandinDepartment of Psychology, Center for Development and Behavioral Neuroscience, Binghamton University, Binghamton, NY 13902, USA.
A L MorrowDepartments of Psychiatry and Pharmacology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
D F WernerDepartment of Psychology, Center for Development and Behavioral Neuroscience, Binghamton University, Binghamton, NY 13902, USA.
I SpigelmanDivision of Oral Biology & Medicine, School of Dentistry, 63-078 CHS, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: igor@ucla.edu.
Binghamton University · USUniversity of California, Los Angeles · USUniversity of North Carolina at Chapel Hill · USUniversity of the Sciences · US

Funding

UNC ARC Information/Dissemination CoreP60AA011605 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A Herman · 2003 to 2026
$46.3M
MOLECULAR AND CELLULAR PATHOGENESIS IN ALCOHOLISMP50AA011605 · NIAAA · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI CREWS, FULTON T · 1998 to 2002
$4.9M
Mechanisms of GABAA Receptor Plasticity in AlcoholismR01AA016100 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SPIGELMAN, IGOR · 2007 to 2011
$1.7M
Chronic pain and alcohol dependenceR21AA022408 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SPIGELMAN, IGOR · 2013 to 2014
$399k
Cellular mechanisms of HPA axis neuroadaptations in alcohol dependenceR21AA022707 · NIAAA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SPIGELMAN, IGOR · 2014 to 2015
$383k
NIAAA NIH HHS P50 AA011605NIAAA NIH HHS P60 AA011605NIAAA NIH HHS R01 AA016100NIAAA NIH HHS R21 AA022408NIAAA NIH HHS R21 AA022707
6 · The paper itself

Abstract

Mounting evidence indicates that ethanol (EtOH) exposure activates neuroimmune signaling. Alterations in pro-inflammatory cytokines after acute and chronic EtOH exposure have been heavily investigated. In contrast, little is known about the regulation of neurotransmission and/or modulation by anti-inflammatory cytokines in the brain after an acute EtOH exposure. Recent evidence suggests that interleukin-10 (IL-10), an anti-inflammatory cytokine, is upregulated during withdrawal from chronic EtOH exposure. In the present study, we show that IL-10 is increased early (1 h) after a single intoxicating dose of EtOH (5 g/kg, intragastric) in Sprague Dawley rats. We also show that IL-10 rapidly regulates GABAergic transmission in dentate gyrus neurons. In brain slice recordings, IL-10 application dose-dependently decreases miniature inhibitory postsynaptic current (mIPSC) area and frequency, and decreases the magnitude of the picrotoxin sensitive tonic current (Itonic), indicating both pre- and postsynaptic mechanisms. A PI3K inhibitor LY294002 (but not the negative control LY303511) ablated the inhibitory effects of IL-10 on mIPSC area and Itonic, but not on mIPSC frequency, indicating the involvement of PI3K in postsynaptic effects of IL-10 on GABAergic transmission. Lastly, we also identify a novel neurobehavioral regulation of EtOH sensitivity by IL-10, whereby IL-10 attenuates acute EtOH-induced hypnosis. These results suggest that EtOH causes an early release of IL-10 in the brain, which may contribute to neuronal hyperexcitability as well as disturbed sleep seen after binge exposure to EtOH. These results also identify IL-10 signaling as a potential therapeutic target in alcohol-use disorders and other CNS disorders where GABAergic transmission is altered.

Indexed as

AnimalsBinge DrinkingBrainCells, CulturedCentral Nervous System DepressantsDisease Models, AnimalDose-Response Relationship, DrugEthanolgamma-Aminobutyric AcidHypnotics and SedativesInhibitory Postsynaptic PotentialsInterleukin-10MaleMiniature Postsynaptic PotentialsNeuronsPhosphatidylinositol 3-KinasesCentral Nervous System DepressantsEthanolgamma-Aminobutyric AcidHypnotics and SedativesInterleukin-10Phosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsReceptors, GABA-AAlcoholAnti-inflammatoryGABAAInterleukin-10mIPSCNeuroimmune

Identifiers

PMID27016017
PMCPMC5076550
OpenAlexW2311254767

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.